One such commonly used medication for dermatologic and rheumatologic inflammatory conditions is hydroxychloroquine (Plaquenil), a chloroquine derivative. It is used to treat many diseases including malaria, rheumatoid arthritis and systemic lupus erythematosus. Hydroxychloroquine dose for malaria Is hydroxychloroquine generic Que es el plaquenil y para que sirve Plaquenil Hydroxychloroquine Toxicity Condition/keywords plaquenil toxicity Imaging device Optical coherence tomography system Autofluorescence Description 68-year-old female with 15 year history of plaquenil hydroxychloroquine use. Related files Lyons emphasizes the importance of annual screening and says that, although annual screening is recommended for everyone taking Plaquenil, it is imperative for people who have been taking the medication for more than 10 years, who have a higher incidence of retinal toxicity. Plaquenil-induced toxicity usually will not occur before five years of. The data presented in this article demonstrate the importance of relying on multiple examination methods when screening for chloroquine toxicity. The authors especially emphasize that normal fundus autofluorescence imaging does not rule out the presence of toxic maculopathy. It is imperative that patients and physicians are aware of and watch for this drug’s ocular side effects. Retinal toxicity from hydroxychloroquine is rare, but even if the medication is discontinued, vision loss may be irreversible and may continue to progress. Plaquenil toxicity autofluorescence Hydroxychloroquine-Induced Retinal Toxicity - American., Protecting your eyesight when taking Plaquenil Lupus. Plaquenil reviews for sjogren& 39Chloroquine moa sarcoid Hydroxychloroquine sulfate HCQ, Plaquenil is an analogue of chloroquine CQ, an antimalarial agent, used for the treatment of systemic lupus erythematosus, rheumatoid arthritis and other autoimmune disorders. Its use has been associated with severe retinal toxicity, requiring a discontinuation of therapy. Retinal toxicity associated with chronic exposure to.. FUNDUS AUTOFLUORESCENCE FINDINGS IN EARLY CHLOROQUINE.. Evaluation of Hydroxychloroquine Retinopathy Using Ultra.. Autofluorescence imaging—commonly using a 488-nm Scanning Laser Ophthalmoscope to detect lipofuscin autofluorescence—may detect early photoreceptor damage. Progressive hydroxychloroquine toxicity mimicking low-tension glaucoma after discontinuation of the drug. Hydroxychloroquine HCQ has been used for therapy of rheumatologic disorders since the 1950s. Ocular toxicity associated with HCQ use was initially described in the 1960s 1, 2incidence of HCQ retinopathy is estimated at 1 % after consumption of HCQ for 5 years is marked by paracentral and central scotoma and decreased color vision. Hydroxychloroquine, sold under the brand name Plaquenil Sanofi-Aventis, is an antimalarial drug that has gained widespread use in treating various autoimmune diseases, including systemic lupus erythematosus and rheumatoid arthritis. 1 By some estimates, more than 150,000 patients are on long-term therapy with this medication in America alone. 2 Retinal toxicity associated with HCQ use is.